Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutations.

Outcome of older adults with cytogenetically normal AML (CN-AML) and FLT3 mutations. Leuk Res. 2011 Dec; 35(12):1611-5.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.